Exagen Inc (XGN) stock news · rev $66.6M
Exagen Inc (XGN) is a diagnostics & research company listed on US.
This XGN news page leads with what Exagen Inc filed — not a scraped headline mill.
No cached 8-K sentence for XGN yet. We will not pad this page with generic market recap.
Latest reported XGN revenue for 2025-12-31 was $66.6M. Net income was -$20.0M. Revenue was up 19.7% from 2024-12-31 to 2025-12-31. XGN currently screens at market cap $154.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the XGN stock page; for the tape open the quote page.
XGN stock news FAQ
What are XGN's latest revenue and net income?
Latest cached Exagen Inc (XGN) revenue for Dec 31, 2025 was $66.6M. Net income was -$20.0M. Statements: https://lician.com/financials/xgn
How did XGN revenue change from the prior cached period?
Cached Exagen Inc (XGN) revenue was up 19.7% from $55.6M (Dec 31, 2024) to $66.6M (Dec 31, 2025). Statements: https://lician.com/financials/xgn
What is XGN's market cap?
Exagen Inc (XGN) market cap is $154.1M on the latest cached fundamentals snapshot.
What kind of company is XGN?
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Where is XGN stock news listed?
Cached stock news for Exagen Inc (XGN) is listed at https://lician.com/news/xgn. Filings: https://lician.com/sec/xgn
Not investment advice.